Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease-Reference-Cited by-同舟云学术

Chronic nephrotoxicity limits successful use of Tacrolimus in the management of adult steroid-dependent minimal change disease

Published:2015-04-15 Issue:5 Volume:20 Page:384-385
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Ramachandran Raja¹,DA Pramod Kumar²,Nada Ritambhra³,Jha Vivekanand¹,Gupta Krishan Lal¹,Kohli HS¹

Affiliation:

1. Department of Nephrology; Post Graduate Institute of Medical Education and Research; Chandigarh India

2. Department of Internal Medicine; Post Graduate Institute of Medical Education and Research; Chandigarh India

3. Department of Histopathology; Post Graduate Institute of Medical Education and Research; Chandigarh India

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/nep.12392/fullpdf

Reference6 articles.

1. Clinical Practice Guideline for glomerulonephritis;KDIGO;Kidney Int.,2012

2. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome;Li;Nephrol. Dial. Transplant.,2008

3. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome;Westhoff;Clin. Nephrol.,2006

4. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial;Ponticelli;Nephrol. Dial. Transplant.,1993

5. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea;Lee;Clin. Nephrol.,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunosuppression for adult steroid-dependent or frequently relapsing nephrotic syndrome: A systematic review and meta-analysis;PLOS ONE;2024-07-31

2. Rituximab in maintaining remission in adults with podocytopathy;Nephrology;2020-06-14

3. Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels;International Immunopharmacology;2020-04

4. Persistent CD‐19 depletion by rituximab is cost‐effective in maintaining remission in calcineurin‐inhibitor dependent podocytopathy;Nephrology;2019-05

5. Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide;Kidney International Reports;2017-07